Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share (INZY)

Historical Holders from Q3 2020 to Q3 2025

Symbol
INZY
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
64,967,756
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-85
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share (INZY)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GLAZER CAPITAL, LLC 6.59% $5,017,289 4,251,940 Glazer Capital, LLC 28 May 2025
BlackRock, Inc. 4.1% $10,654,712 2,663,678 BlackRock, Inc. 30 Jun 2025
EVENTIDE ASSET MANAGEMENT, LLC 3.46% $2,353,200 2,220,000 Eventide Asset Management, LLC 31 Dec 2024
Affinity Asset Advisors, LLC 2.89% $2,203,898 1,867,710 Affinity Healthcare Fund, LP 20 May 2025

Institutional Holders of Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share (INZY)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 0 $0 -$202,243,928 0
2025 Q2 50,562,361 $202,249,948 +$62,663,536 $4 86
2025 Q1 46,721,833 $42,516,032 -$10,880,581 $0.91 97
2024 Q4 52,395,972 $145,138,301 -$16,307,259 $2.77 103
2024 Q3 54,589,806 $285,504,883 +$3,379,521 $5.23 88
2024 Q2 53,828,193 $240,074,209 +$12,985,182 $4.46 89
2024 Q1 49,873,972 $382,034,841 +$1,504,861 $7.66 87
2023 Q4 50,074,744 $213,326,471 +$10,707,274 $4.26 80
2023 Q3 48,723,016 $204,637,627 +$58,070,290 $4.2 77
2023 Q2 34,159,156 $190,263,189 +$11,847,095 $5.57 73
2023 Q1 32,010,444 $183,415,554 +$30,509,947 $5.73 49
2022 Q4 28,942,741 $30,390,733 -$8,198,128 $1.05 35
2022 Q3 30,838,062 $82,660,000 -$2,021,696 $2.68 36
2022 Q2 19,877,308 $93,682,000 +$36,395,969 $4.77 29
2022 Q1 17,407,532 $71,181,000 -$1,929,409 $4.09 48
2021 Q4 17,329,319 $118,150,000 -$3,845,992 $6.82 49
2021 Q3 17,485,375 $202,661,000 -$49,050,765 $11.59 50
2021 Q2 19,782,677 $337,098,000 +$9,908,694 $17.04 47
2021 Q1 19,164,354 $379,443,000 +$15,463,166 $19.8 55
2020 Q4 18,360,151 $378,973,000 +$7,774,419 $20.64 53
2020 Q3 16,305,719 $428,665,000 +$428,665,000 $26.29 52